TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29388417

Group type: EXPERIMENTAL
Intervention: Tooth-borne distraction osteogenesis (DO); activated twice daily by a total amount of 0.5 mm per day for 3 weeks after a 7-day latency period.
Number of subjects: 21

Group type: COMPARATOR
Intervention: Conventional Le Fort 1 osteotomy; pre and postsurgery lateral cephalograms obtained.
Number of subjects: 21
Study: 26086397

Group type: EXPERIMENTAL
Intervention: Viewing the orientation re-enactment DVD prior to placement
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (did not view the DVD)
Number of subjects: 47
Study: 26048054

Group type: EXPERIMENTAL
Intervention: Perturbation training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional balance training
Number of subjects: 0
Study: 23835824

Group type: EXPERIMENTAL
Intervention: Enhanced practice approach using AIM-HI tools
Number of subjects: 610

Group type: COMPARATOR
Intervention: Traditional practice approach using AIM-HI tools
Number of subjects: 610
Study: 20675956

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme (ACE) inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Angiotensin II-receptor blockers (ARBs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dual blockade of the renin-angiotensin system (RAS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: ACE inhibitors or ARBs
Number of subjects: 0
Study: 18436085

Group type: EXPERIMENTAL
Intervention: Individualized dietary counseling with regular follow-up (aimed at achieving an intake of 0.8 to 1.0 g/kg of protein and greater than 125 kJ/kg of energy)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Written material only (control)
Number of subjects: 56
Study: 17283863

Group type: EXPERIMENTAL
Intervention: Azelnidipine 8‐16 mg/day
Number of subjects: 108

Group type: COMPARATOR
Intervention: Amlodipine 2.5‐5 mg/day
Number of subjects: 108
Study: 12805334

Group type: COMPARATOR
Intervention: Arsenic trioxide (ATO) alone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Arsenic trioxide (ATO) plus all-trans-retinoic acid (ATRA)
Number of subjects: 20
Study: 10805607

Group type: EXPERIMENTAL
Intervention: EHR (Progynova TS, transdermal estradiol; n=19)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo (n=18)
Number of subjects: 37
Study: 8793308

Group type: EXPERIMENTAL
Intervention: Residential relapse prevention/health education treatment
Number of subjects: 140
Study: 1451289

Group type: EXPERIMENTAL
Intervention: Topical fish oil (FO) applied daily for 6 hours under an occlusive dressing for 4 weeks
Number of subjects: 25

Group type: COMPARATOR
Intervention: Liquid paraffin (LP) applied daily for 6 hours under an occlusive dressing for 4 weeks
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Topical fish oil (FO)
Number of subjects: 25
Study: 6362961

Group type: EXPERIMENTAL
Intervention: Guar gum
Number of subjects: 0
Study: 31246895

Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate
Number of subjects: 4011

Group type: COMPARATOR
Intervention: No glyceryl trinitrate
Number of subjects: 4011
Study: 29902305

Group type: EXPERIMENTAL
Intervention: Very low-nicotine-content cigarettes (VLNCCs)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Normal-nicotine-content cigarettes (NNCCs)
Number of subjects: 238
Study: 26907502

Group type: EXPERIMENTAL
Intervention: Wii-based Movement Therapy (WMT)
Number of subjects: 46

Group type: COMPARATOR
Intervention: modified Constraint‐induced Movement Therapy (mCIMT)
Number of subjects: 46
Study: 23130813

Group type: EXPERIMENTAL
Intervention: Negative evaluation/social rejection
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Negative evaluation/academic (writing)
Number of subjects: 74
Study: 22770852

Group type: EXPERIMENTAL
Intervention: Combined femoral nerve block and sciatic nerve block (FNB-SNB)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Combined femoral nerve block and periarticular infiltration (FNB-PI)
Number of subjects: 52
Study: 19852905

Group type: EXPERIMENTAL
Intervention: Patients with comorbidities (suicidality and/or substance use)
Number of subjects: 498

Group type: COMPARATOR
Intervention: Patients without comorbidities
Number of subjects: 498
Study: 17852084

Group type: EXPERIMENTAL
Intervention: Narrowband ultraviolet B (NB-UVB) radiation
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Systemic photochemotherapy (psoralen plus UVA - PUVA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 50
Study: 16208658

Group type: EXPERIMENTAL
Intervention: Multidisciplinary job-retention vocational rehabilitation program (n = 74)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Usual outpatient care (n = 66)
Number of subjects: 140
Study: 12432015

Group type: EXPERIMENTAL
Intervention: Respiratory muscle training (RMT; 20x 30 min sessions of voluntary normocapnic hyperpnea)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Respiratory muscle training (RMT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 10079415

Group type: EXPERIMENTAL
Intervention: High-intensity strength training (80% of maximum)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Flexibility training
Number of subjects: 38
Study: 7580639

Group type: EXPERIMENTAL
Intervention: Laparoscopic repair
Number of subjects: 125

Group type: COMPARATOR
Intervention: Open repair
Number of subjects: 125
Study: 1302542

Group type: EXPERIMENTAL
Intervention: Xiao Wei Yan Powder (XWYP), 5-7g taken orally three times a day (tid) for 2-4 months.
Number of subjects: 242

Group type: COMPARATOR
Intervention: Control group (not specified what the control was).
Number of subjects: 242
Study: 3927338

Group type: EXPERIMENTAL
Intervention: Marijuana
Number of subjects: 0
Study: 29947099

Group type: EXPERIMENTAL
Intervention: Dapagliflozin plus saxagliptin
Number of subjects: 939

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 939

Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 939

Group type: EXPERIMENTAL
Intervention: Dapagliflozin regimens
Number of subjects: 939
Study: 27362794

Group type: EXPERIMENTAL
Intervention: Circulating microRNAs
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: FEV1/FVC microRNAs
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Ontology analyses
Number of subjects: 160
Study: 25602143

Group type: EXPERIMENTAL
Intervention: Sprint Interval Training (SIT); 3 bouts/week of 4-8 30-s cycle sprints with 4-min recovery for 6 weeks
Number of subjects: 47

Group type: COMPARATOR
Intervention: Nonexercise control condition (CON)
Number of subjects: 47
Study: 22261127

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO(4)) discontinued after 6 hours postpartum
Number of subjects: 150

Group type: COMPARATOR
Intervention: Magnesium sulfate (MgSO(4)) continued for 24 hours postpartum
Number of subjects: 150
Study: 19965915

Group type: EXPERIMENTAL
Intervention: ezetimibe (10 mg/d)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: simvastatin (10 mg/d)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: ezetimibe + simvastatin
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Combination therapy (ezetimibe + simvastatin)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: ezetimibe
Number of subjects: 215
Study: 18340009

Group type: EXPERIMENTAL
Intervention: 20 mg/d fluvastatin
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 80 mg/d atorvastatin
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 16007894

Group type: EXPERIMENTAL
Intervention: External beam radiotherapy (RT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: External beam RT in association with androgen suppression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: External beam RT as a postoperative adjunct
Number of subjects: 0
Study: 12429759

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy with three treatments of 2000 pulses each and a positive energy flux density (ED+) of 0.07 to 0.09 mJ/mm²
Number of subjects: 272

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 272

Group type: COMPARATOR
Intervention: Extracorporeal shock wave therapy and Placebo therapy
Number of subjects: 272
Study: 9564925

Group type: EXPERIMENTAL
Intervention: Catheter irrigation
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Muscle flap closure
Number of subjects: 25

Group type: COMPARATOR
Intervention: Catheter irrigation (successful)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Catheter irrigation (unsuccessful)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Muscle flap closure (primary)
Number of subjects: 25
Study: 7826828

Group type: EXPERIMENTAL
Intervention: Fluvastatin 2.5 mg day-1
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Fluvastatin 5 mg day-1
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Fluvastatin 10 mg day-1
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Fluvastatin 20 mg day-1
Number of subjects: 431

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 431
Study: 2901122

Group type: EXPERIMENTAL
Intervention: Acebutolol (400 mg once daily)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg once daily)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29633389

Group type: EXPERIMENTAL
Intervention: SOF + NS5A without RBV for 12 weeks (156 patients)
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: SOF + NS5A without RBV for 24 weeks (239 patients)
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: SOF + NS5A + RBV for 12 weeks (47 patients)
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: SOF + NS5A + RBV for 24 weeks (70 patients)
Number of subjects: 512

Group type: COMPARATOR
Intervention: RBV group (adverse events)
Number of subjects: 512
Study: 27072153

Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - Six-hour nurse-led interactive group education programme
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control Group (CG) - Standard information
Number of subjects: 156
Study: 25748084

Group type: EXPERIMENTAL
Intervention: Biomedical educational text
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Psychosocial educational text
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Bio‐psychosocial educational text
Number of subjects: 130

Group type: COMPARATOR
Intervention: Baseline assessment
Number of subjects: 130
Study: 23827820

Group type: EXPERIMENTAL
Intervention: Jitai tablets (JTT)
Number of subjects: 386

Group type: COMPARATOR
Intervention: Methadone
Number of subjects: 386
Study: 20629478

Group type: EXPERIMENTAL
Intervention: Dairy interventions (including low lactose intake) in children and adult women
Number of subjects: 223336

Group type: COMPARATOR
Intervention: Lactose doses of 0-2 grams (lactose-reduced solution/milk)
Number of subjects: 223336

Group type: COMPARATOR
Intervention: Probiotics
Number of subjects: 223336

Group type: COMPARATOR
Intervention: Colonic adaptation
Number of subjects: 223336

Group type: COMPARATOR
Intervention: Varying lactose doses
Number of subjects: 223336

Group type: COMPARATOR
Intervention: Other agents (not specified)
Number of subjects: 223336

Group type: EXPERIMENTAL
Intervention: Lactose doses of 12-15 grams
Number of subjects: 223336

Group type: COMPARATOR
Intervention: Lactose doses above 12 grams
Number of subjects: 223336
Study: 18652862

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate low-fat (LCLF) diet
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: High-carbohydrate low-fat (HCLF) diet
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate high-fat (LCHF) diet
Number of subjects: 71

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 71
Study: 17132757

Group type: EXPERIMENTAL
Intervention: Testosterone plus exercise (Group 1)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Testosterone plus no exercise (Group 2)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo plus exercise (Group 3)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo plus no exercise (Group 4)
Number of subjects: 70
Study: 12970727

Group type: EXPERIMENTAL
Intervention: Entonox (nitrous oxide)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Air
Number of subjects: 50
Study: 10743444

Group type: EXPERIMENTAL
Intervention: 0.2% ropivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.2% bupivacaine
Number of subjects: 60
Study: 9111824

Group type: EXPERIMENTAL
Intervention: Ketoconazole 2% shampoo
Number of subjects: 20
Study: 8113481

Group type: COMPARATOR
Intervention: Standard Behavioral Treatment (SBT)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: SBT plus food provision
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: SBT plus incentives
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: SBT plus food provision and incentives
Number of subjects: 202
Study: 3945045

Group type: EXPERIMENTAL
Intervention: Ferrous sulphate (80 mg Fe++ three times daily) for 6 weeks
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no iron therapy)
Number of subjects: 32
Study: 30215785

Group type: EXPERIMENTAL
Intervention: 21‐mg nicotine patch for 24 weeks with behavior counseling
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: 21‐mg nicotine patch for 8 weeks with behavior counseling
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: 21‐mg nicotine patch for 52 weeks with behavior counseling
Number of subjects: 525
Study: 30117915

Group type: EXPERIMENTAL
Intervention: Deformable mirror technology
Number of subjects: 0

Group type: COMPARATOR
Intervention: Moving diffuser
Number of subjects: 0
Study: 27768194

Group type: EXPERIMENTAL
Intervention: Hearing aids plus ReadMyQuips training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Hearing aids only
Number of subjects: 24
Study: 24572255

Group type: EXPERIMENTAL
Intervention: Pedometer-only intervention (group 2)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Pedometer with interactive website (group 3)
Number of subjects: 114

Group type: COMPARATOR
Intervention: No intervention (group 1)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Achieving ≥20 min/day in MPA bouts
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Achieving ≥10 000 steps/day or ≥30 min/day of MPA
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Vascular stiffness
Number of subjects: 114
Study: 24498697

Group type: EXPERIMENTAL
Intervention: Group counselling (n=8)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: High-intensity aerobic exercise (n=9)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Initial counselling sessions before physical intervention
Number of subjects: 17
Study: 20027108

Group type: EXPERIMENTAL
Intervention: 30 mg intravenous rolofylline, 4-hour infusions once daily for 4 consecutive days
Number of subjects: 19

Group type: COMPARATOR
Intervention: Single oral dose of midazolam 7.5 mg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 30 mg intravenous rolofylline
Number of subjects: 19
Study: 19071974

Group type: EXPERIMENTAL
Intervention: Antismoking public service announcement (PSA) viewed at least once
Number of subjects: 0
Study: 16148457

Group type: EXPERIMENTAL
Intervention: Terlipressin
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Norepinephrine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both drugs
Number of subjects: 20
Study: 12736829

Group type: EXPERIMENTAL
Intervention: Running
Number of subjects: 10

Group type: COMPARATOR
Intervention: Cycling
Number of subjects: 10
Study: 10586391

Group type: EXPERIMENTAL
Intervention: Theophylline (IV infusion)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Amikacin (IV infusion)
Number of subjects: 18
Study: 8704896

Group type: EXPERIMENTAL
Intervention: Best Start breast-feeding education program
Number of subjects: 90
Study: 1914373

Group type: EXPERIMENTAL
Intervention: 10 mg oral nifedipine
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 7017370

Group type: EXPERIMENTAL
Intervention: Neonatal intensive care
Number of subjects: 410
Study: 31838028

Group type: EXPERIMENTAL
Intervention: Anaferon for children (AC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30461405

Group type: EXPERIMENTAL
Intervention: Programmed telecoil
Number of subjects: 20

Group type: COMPARATOR
Intervention: Default telecoil
Number of subjects: 20
Study: 28368681

Group type: EXPERIMENTAL
Intervention: Readiness to Change (RTC)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Gender (moderator)
Number of subjects: 194
Study: 26916738

Group type: EXPERIMENTAL
Intervention: Nurse-led palliative care intervention
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 30
Study: 23879234

Group type: EXPERIMENTAL
Intervention: Mometasone furoate (MMF) 0.1% ointment for 12 weeks
Number of subjects: 147
Study: 21878580

Group type: EXPERIMENTAL
Intervention: Se+highI (100 μg selenium + >50 mg iodine as iodate/day for 8 weeks)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: highI (>50 mg iodine as iodate/day for 8 weeks)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Se+lowI (80 μg iodine as iodate/day + selenium)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Se+ (selenium alone)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: lowI (80 μg iodine as iodate/day without selenium)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143
Study: 18645345

Group type: EXPERIMENTAL
Intervention: Dopamine infusion (0.5-3 microg/kg/min)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Metoclopramide (7.5 microg/kg/min)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Metoclopramide (7.5 microg/kg/min) plus dopamine (0.5-3 microg/kg/min)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Metoclopramide and dopamine
Number of subjects: 30
Study: 17135607

Group type: EXPERIMENTAL
Intervention: Resistance exercise (RX) for 6 months
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control non-exercise group
Number of subjects: 49
Study: 12973291

Group type: EXPERIMENTAL
Intervention: Citric acid 50% at original pH
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Citric acid 25% at original pH
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Citric acid 10% at original pH
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Citric acid 5% at original pH
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Citric acid buffered to pH 6
Number of subjects: 50

Group type: COMPARATOR
Intervention: Bidistilled water
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sodium hypochlorite (NaOCl)
Number of subjects: 50
Study: 10735695

Group type: EXPERIMENTAL
Intervention: High-dose aprotinin (Trasylol)
Number of subjects: 60
Study: 8655886

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aqueous nasal spray (200 micrograms once daily)
Number of subjects: 348

Group type: COMPARATOR
Intervention: Terfenadine tablets (60 mg twice daily)
Number of subjects: 348

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 348
Study: 1419105

Group type: EXPERIMENTAL
Intervention: Ondansetron plus dexamethasone
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Tropisetron plus dexamethasone
Number of subjects: 47
Study: 3966746

Group type: EXPERIMENTAL
Intervention: Initial amplitude of ventricular fibrillation (average 0.55 +/- 0.25 mV)
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Fine ventricular fibrillation (0.2 mV or less)
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Delay in initiation of treatment
Number of subjects: 394
Study: 31747018

Group type: EXPERIMENTAL
Intervention: Lenient rate control
Number of subjects: 614

Group type: COMPARATOR
Intervention: Strict rate control
Number of subjects: 614

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 614

Group type: COMPARATOR
Intervention: Men
Number of subjects: 614
Study: 30917302

Group type: EXPERIMENTAL
Intervention: 0.15% benzydamine hydrochloride (Tantum Verde®) mouthwash solution
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 39
Study: 28195990

Group type: EXPERIMENTAL
Intervention: Supervised, multicomponent, adapted exercise program (approximately 20 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sedentary women
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active women
Number of subjects: 0
Study: 26271204

Group type: EXPERIMENTAL
Intervention: VAC (vincristine, adriamycin, cyclophosphamide)
Number of subjects: 856

Group type: COMPARATOR
Intervention: VAI (vincristine, adriamycin, ifosfamide)
Number of subjects: 856

Group type: EXPERIMENTAL
Intervention: VAC
Number of subjects: 856

Group type: COMPARATOR
Intervention: VAI
Number of subjects: 856
Study: 23241227

Group type: EXPERIMENTAL
Intervention: Ranibizumab monotherapy
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Combined treatment (Ranibizumab + PDT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 44
Study: 21496998

Group type: EXPERIMENTAL
Intervention: Hilotherm cooling therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional cooling with cooling compresses
Number of subjects: 30
Study: 19085267

Group type: EXPERIMENTAL
Intervention: Combination of sedating H1 antihistamine and non‐sedating H1 antihistamine (Group A)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Combination of H1 antihistamine and H2 antihistamine (Group B)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Combination of H1 antihistamine and leukotriene receptor antagonist (LRA) (Group C)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Matched placebo medication (Group D)
Number of subjects: 120
Study: 17018229

Group type: EXPERIMENTAL
Intervention: Endoscopy performed by nurses
Number of subjects: 4128

Group type: COMPARATOR
Intervention: Endoscopy performed by doctors
Number of subjects: 4128
Study: 14630840

Group type: EXPERIMENTAL
Intervention: Oral alendronate at a dose of 10 mg/day for six months
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (no alendronate)
Number of subjects: 96
Study: 10832506

Group type: EXPERIMENTAL
Intervention: Sahaja Yoga meditation twice daily for 6 months
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Postural exercises mimicking meditation for 6 months
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 32
Study: 9106568

Group type: EXPERIMENTAL
Intervention: RIP waveforms (VRIP.BP(t) and VRIP.PNT(t))
Number of subjects: 11
Study: 1551954

Group type: EXPERIMENTAL
Intervention: Short 3 day regimen of leuprolide acetate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Long-term leuprolide acetate
Number of subjects: 0